HSR25-150: Meta-Analysis of Randomized Controlled Trials (RCTs) to Evaluate the Incidence of Health-Related Quality of Life (HRQOL) Events in Patients with Primary Advanced or Recurrent Endometrial Cancer Treated With First-Line Immunochemotherapy
"HSR25-150: Meta-Analysis of Randomized Controlled Trials (RCTs) to Evaluate the Incidence of Health-Related Quality of Life (HRQOL) Events in Patients with Primary Advanced or Recurrent Endometrial Cancer Treated With First-Line Immunochemotherapy" published on 28 Mar 2025 by National Comprehensive Cancer Network.
Authors
- Kyaw Zin Thein (ORCID: https://orcid.org/0000-0003-1518-1097)
- Hazem Aboaid (ORCID: https://orcid.org/0000-0002-3085-1549)
- Kevin Nguyen
- Yin Mon Myat (ORCID: https://orcid.org/0009-0004-3799-7067)
- Jason Ta (ORCID: https://orcid.org/0009-0005-8514-2781)
- Tzer‐Ming Chuang (ORCID: https://orcid.org/0000-0003-1903-0042)
- Ramaditya Srinivasmurthy
- Daniel T. Jones
- Rishi Kumar Nanda
Institutions
- University of Nevada, Las Vegas (US)
- Interfaith Medical Center (US)
- St. Rose Dominican Hospital (US)
- Comprehensive Cancer Centers of Nevada (US)
- Touro University Nevada (US)
Publication Details
- Journal
- Journal of the National Comprehensive Cancer Network
- Published
- 2025-03-28
- DOI
- https://doi.org/10.6004/jnccn.2024.7342
- Primary Topic
- Endometrial and Cervical Cancer Treatments
- Type
- article
- Field-Weighted Citation Impact
- 0.00